Savient Pharmaceuticals News

Today the Chicago Sun-Times paid $1,000 in exchange for 438 words by the entertainer Jenny McCarthy on the differences between men in Chicago and men in Los Angeles .

The report covers the companys structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360A view of the company.

Aside from Allergan coming to Bridgewater in the next few months, several other pharmaceutical and technological companies are making their homes in town in the near future.

EAST BRUNSWICK, N.J., May 9, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. today reported financial results for the three months ended March 31, 2012, which reflects the Company's continuing commercialization of KRYSTEXXA in the U.S. Savient ended the quarter with approximately $131.0 million in cash and short-term investments.

EAST BRUNSWICK, N.J., May 8, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. today announced that the Company has entered into definitive agreements with certain holders of its currently outstanding 4.75% convertible senior notes due 2018 .

Savient Pharmaceuticals Inc said a Delaware court denied a request for an injunction by its largest creditor, Tang Capital Partners, to halt Savient's plan to raise about $44 million and extend the maturity date on certain debt.

Savient Pharmaceuticals nnounced that the company has entered into definitive agreements with certain holders of its currently outstanding 4.75% convertible senior notes due 2018.

The iShares NASDAQ Biotechnology Index is up nearly 20 percent year-to-date. The passage of the America Invents Act will look to benefit the Biotechnology Industry going forward "by enhancing patent quality and the efficiency, objectivity, predictability and transparency of the U.S. patent system." BIO President and CEO Jim Greenwood stated in a ... (more)

You saw the headlines. You know your stock price made a big move. But what does that portend for your investment's future ? By pairing the latest news with the collective wisdom of our 180,000-strongA Motley Fool CAPS investing community, we might be able to discover whether your stock's latest exploits are a short-term hiccup -- or the start of a ... (more)

EAST BRUNSWICK, N.J., May 3, 2012 /PRNewswire/ -- Savient Pharmaceuticals, Inc. today announced that the Company will present at the Bank of America Merrill Lynch 2012 Health Care Conference on Thursday, May 17, 2012, at 11:20 a.m. PT.

HOTBEDS Regional News US & Canada Biotech Bay Biotech Beach Genetown Pharm Country BioCapital BioMidwest Bio NC BioForest Southern Pharm BioCanada East US Device Europe Asia Savient Pharmaceuticals is insolvent and its directors are greedy pigs more interested in emptying the company's dwindling cash pile into their own pockets than repaying ... (more)